Barclays’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $34.1M | Buy |
271,390
+71,172
| +36% | +$8.95M | 0.01% | 635 |
|
|
2025
Q1 | $22.1M | Buy |
200,218
+21,850
| +12% | +$2.42M | 0.01% | 706 |
|
|
2024
Q4 | $24.3M | Sell |
178,368
-3,223
| -2% | -$440K | 0.01% | 712 |
|
|
2024
Q3 | $20.9M | Buy |
181,591
+19,202
| +12% | +$2.21M | 0.01% | 735 |
|
|
2024
Q2 | $22.4M | Sell |
162,389
-94,850
| -37% | -$13.1M | 0.01% | 680 |
|
|
2024
Q1 | $35.5M | Buy |
257,239
+25,071
| +11% | +$3.46M | 0.01% | 590 |
|
|
2023
Q4 | $30.6M | Buy |
232,168
+53,905
| +30% | +$7.1M | 0.01% | 638 |
|
|
2023
Q3 | $20.1M | Sell |
178,263
-16,259
| -8% | -$1.83M | 0.01% | 673 |
|
|
2023
Q2 | $18.3M | Sell |
194,522
-53,472
| -22% | -$5.04M | 0.01% | 706 |
|
|
2023
Q1 | $25.1M | Buy |
247,994
+92,208
| +59% | +$9.33M | 0.01% | 541 |
|
|
2022
Q4 | $18.6M | Buy |
155,786
+9,183
| +6% | +$1.1M | 0.01% | 666 |
|
|
2022
Q3 | $15.6M | Buy |
146,603
+27,837
| +23% | +$2.96M | 0.02% | 673 |
|
|
2022
Q2 | $11.6M | Buy |
118,766
+4,055
| +4% | +$395K | 0.01% | 772 |
|
|
2022
Q1 | $10.8M | Sell |
114,711
-17,676
| -13% | -$1.66M | 0.01% | 838 |
|
|
2021
Q4 | $11.3M | Sell |
132,387
-23,000
| -15% | -$1.96M | ﹤0.01% | 854 |
|
|
2021
Q3 | $14.9M | Sell |
155,387
-47,617
| -23% | -$4.57M | 0.01% | 783 |
|
|
2021
Q2 | $19.8M | Buy |
203,004
+127,576
| +169% | +$12.4M | 0.01% | 693 |
|
|
2021
Q1 | $7.34M | Buy |
75,428
+36,573
| +94% | +$3.56M | ﹤0.01% | 951 |
|
|
2020
Q4 | $3.72M | Sell |
38,855
-33,124
| -46% | -$3.17M | ﹤0.01% | 1174 |
|
|
2020
Q3 | $6.92M | Buy |
71,979
+28,431
| +65% | +$2.73M | ﹤0.01% | 835 |
|
|
2020
Q2 | $5.31M | Buy |
43,548
+12,558
| +41% | +$1.53M | ﹤0.01% | 903 |
|
|
2020
Q1 | $2.68M | Sell |
30,990
-40,014
| -56% | -$3.46M | ﹤0.01% | 1183 |
|
|
2019
Q4 | $7.63M | Buy |
71,004
+18,501
| +35% | +$1.99M | ﹤0.01% | 966 |
|
|
2019
Q3 | $4.73M | Sell |
52,503
-32,557
| -38% | -$2.93M | ﹤0.01% | 1121 |
|
|
2019
Q2 | $7.18M | Buy |
85,060
+1,818
| +2% | +$154K | ﹤0.01% | 937 |
|
|
2019
Q1 | $7.33M | Buy |
83,242
+6,091
| +8% | +$537K | 0.01% | 855 |
|
|
2018
Q4 | $5.51M | Buy |
77,151
+52,969
| +219% | +$3.78M | ﹤0.01% | 903 |
|
|
2018
Q3 | $2.97M | Buy |
24,182
+1,758
| +8% | +$216K | ﹤0.01% | 1467 |
|
|
2018
Q2 | $2.2M | Sell |
22,424
-15,989
| -42% | -$1.57M | ﹤0.01% | 1390 |
|
|
2018
Q1 | $3.19M | Buy |
38,413
+5,274
| +16% | +$437K | ﹤0.01% | 1110 |
|
|
2017
Q4 | $2.57M | Sell |
33,139
-337
| -1% | -$26.2K | ﹤0.01% | 1142 |
|
|
2017
Q3 | $2.05M | Buy |
33,476
+13,285
| +66% | +$814K | ﹤0.01% | 1220 |
|
|
2017
Q2 | $928K | Buy |
20,191
+9,618
| +91% | +$442K | ﹤0.01% | 1604 |
|
|
2017
Q1 | $458K | Sell |
10,573
-90,042
| -89% | -$3.9M | ﹤0.01% | 2002 |
|
|
2016
Q4 | $3.9M | Buy |
100,615
+93,196
| +1,256% | +$3.61M | ﹤0.01% | 848 |
|
|
2016
Q3 | $375K | Sell |
7,419
-29,147
| -80% | -$1.47M | ﹤0.01% | 1862 |
|
|
2016
Q2 | $1.66M | Buy |
36,566
+13,129
| +56% | +$597K | ﹤0.01% | 1190 |
|
|
2016
Q1 | $914K | Sell |
23,437
-27,030
| -54% | -$1.05M | ﹤0.01% | 1438 |
|
|
2015
Q4 | $2.83M | Sell |
50,467
-34,791
| -41% | -$1.95M | ﹤0.01% | 913 |
|
|
2015
Q3 | $3.33M | Buy |
85,258
+65,748
| +337% | +$2.56M | ﹤0.01% | 848 |
|
|
2015
Q2 | $915K | Sell |
19,510
-6,208
| -24% | -$291K | ﹤0.01% | 1524 |
|
|
2015
Q1 | $1M | Sell |
25,718
-139,358
| -84% | -$5.43M | ﹤0.01% | 1607 |
|
|
2014
Q4 | $3.63M | Buy |
165,076
+12,717
| +8% | +$280K | ﹤0.01% | 1054 |
|
|
2014
Q3 | $2.29M | Buy |
152,359
+106,580
| +233% | +$1.6M | ﹤0.01% | 1322 |
|
|
2014
Q2 | $641K | Buy |
45,779
+14,918
| +48% | +$209K | ﹤0.01% | 1895 |
|
|
2014
Q1 | $494K | Buy |
30,861
+547
| +2% | +$8.76K | ﹤0.01% | 1996 |
|
|
2013
Q4 | $273K | Sell |
30,314
-80,912
| -73% | -$729K | ﹤0.01% | 2455 |
|
|
2013
Q3 | $1.22M | Buy |
111,226
+37,893
| +52% | +$417K | ﹤0.01% | 1580 |
|
|
2013
Q2 | $981K | Buy |
+73,333
| New | +$981K | ﹤0.01% | 1753 |
|